Enrichment Materials

Buprenorphine-Naloxone Telepsychiatry — Deep Dive Resources for Advanced Learners

Extended Literature Review

Landmark Study: Telehealth Retention Outcomes

D'Onofrio G, et al. "Emergency Department-Initiated Buprenorphine/Naloxone Treatment for Opioid Dependence: A Randomized Clinical Trial." JAMA. 2015;313(16):1636-1646.

Pioneering study demonstrating feasibility of telehealth models for OUD treatment initiation. Found comparable retention rates between telehealth and in-person care at 3-month follow-up.

Critical Appraisal:

Micro-dosing (Bernese Method) Evidence

Hämmig R, et al. "Microinduction of Buprenorphine for the Treatment of Opioid Use Disorder in the Hospital Setting." J Addict Med. 2021;15(1):11-16.

Case series demonstrating safety and efficacy of low-dose buprenorphine initiation in hospitalized patients. Key finding: Avoidance of precipitated withdrawal while maintaining patient comfort.

Remote Urine Drug Screening Validation

Chadi N, et al. "Feasibility and Acceptability of Remote Urine Drug Screening in Telehealth-Based Treatment for Opioid Use Disorder." JAMA Netw Open. 2023;6(4):e237891.

Large cohort study (n=1,247) demonstrating 83% compliance with remote UDS at 30 days. Temperature strips and adulteration testing maintained sample integrity.

Ryan Haight Act Flexibilities: Policy Analysis

Substance Abuse and Mental Health Services Administration. "Telemedicine for Medication-Assisted Treatment for Opioid Use Disorder." SAMHSA Publication No. PEP22-06-002. Rockville, MD: SAMHSA, 2022.

Comprehensive policy review of telehealth prescribing flexibilities for controlled substances. Includes state-by-state regulatory variations and compliance guidance.

Advanced Clinical Tools

COWS Calculator (Full)

Enter values to calculate COWS score

Induction Pathway Selector

Select options for recommendation

Advanced Case Vignettes

Case 1: High-Dose Fentanyl with Cardiac Comorbidity

Presentation: 34-year-old male with 2-year history of fentanyl use (1-2g/day). History of atrial fibrillation on anticoagulation. Lives in rural area 90 minutes from nearest OTP. Has reliable internet, stable housing, supportive partner.

Challenge: High tolerance + cardiac disease + rural location.

Discussion Points:

  • Standard vs. micro-dosing? Why?
  • Cardiac monitoring considerations
  • Frequency of virtual check-ins
  • Safety planning for remote location

Recommended Approach: Micro-dosing induction given fentanyl use and high tolerance. Daily cardiac symptom check (palpitations, chest pain, dyspnea). Partner involvement for safety monitoring. Establish relationship with nearest ED (90 min away) — patient should know route and transport options.

Case 2: Benzodiazepine Co-use with History of Precipitated Withdrawal

Presentation: 28-year-old female on prescribed alprazolam 2mg BID for anxiety (same prescriber). Previous traumatic precipitated withdrawal during past attempt at induction. Uses heroin intermittently (not daily). Highly motivated, lives alone, works remotely.

Challenge: Benzo co-use + PTSD from prior precipitated withdrawal + lives alone.

Discussion Points:

  • Managing benzo-buprenorphine interaction
  • Addressing trauma from prior experience
  • Safety planning for solo living
  • Coordination with anxiety prescriber

Regulatory Updates & Emerging Policy

DEA Special Registration Framework (Proposed)

As of early 2026, the DEA is developing a permanent framework for telemedicine prescribing of controlled substances. Key proposed elements:

State-Level Variations

While federal law provides baseline requirements, states maintain significant regulatory authority:

Teaching Resources

Patient Education Videos
5-10 minute videos on induction process, COWS self-assessment
Safety Plan Template
Fillable PDF with all required components
COWS Training Module
Interactive module for patient self-assessment training
Board-Style Questions
25 question bank with rationales
Tele-MAT Workflow Diagrams
High-resolution flowcharts for clinic use